This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Al-Sarraf M, Le Blanc M, Giri PG, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998; 16: 1310–7.Al-SarrafMLe BlancMGiriPGFuKKCooperJVuongTChemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099J Clin Oncol1998161310710.1200/JCO.1998.16.4.1310Search in Google Scholar
Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an updated of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53: 12–22.LeeNXiaPQuiveyJMSultanemKPoonIAkazawaCIntensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an updated of the UCSF experienceInt J Radiat Oncol Biol Phys200253122210.1016/S0360-3016(02)02724-4Search in Google Scholar
Du L, Zhang XX, Ma L, Feng LC, Li F, Zhou GX, et al. Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes. Biomed Res Int 2014, Article ID: 980767. doi: 10.1155/2014/980767. Epub 2014 Jul 9.DuLZhangXXMaLFengLCLiFZhouGXClinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomesBiomed Res Int2014Article ID: 980767. doi:10.1155/2014/980767Epub 2014 Jul 9.Search in Google Scholar
Fowler JF. A review: the linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679–94.FowlerJFA review: the linear quadratic formula and progress in fractionated radiotherapyBr J Radiol1989626799410.1259/0007-1285-62-740-679Search in Google Scholar
Fowler J F. 21 years of biologically effective dose. Br J Radiol 2010; 83: 554–68.FowlerJF21 years of biologically effective doseBr J Radiol2010835546810.1259/bjr/31372149Search in Google Scholar
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–6.CoxJDStetzJPajakTFToxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)Int J Radiat Oncol Biol Phys1995311341610.1016/0360-3016(95)00060-CSearch in Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–47.EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer2009452284710.1016/j.ejca.2008.10.026Search in Google Scholar
Lee AW, Law SC, Foo W, Poon YF, Chan DK, O SK, et al. Nasopharyngeal carcinoma: local control by megavoltage irradiation. Br J Radiol 1993; 66: 528–36.LeeAWLawSCFooWPoonYFChanDKOSKNasopharyngeal carcinoma: local control by megavoltage irradiationBr J Radiol1993665283610.1259/0007-1285-66-786-528Search in Google Scholar
Withers HR, Tayor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46.WithersHRTayorJMMaciejewskiBThe hazard of accelerated tumor clonogen repopulation during radiotherapyActa Oncol1988271314610.3109/02841868809090333Search in Google Scholar
Withers HR. Biologic basis for altered fractionation schemes. Cancer 1985; 55(9 Suppl): 2086–95.WithersHRBiologic basis for altered fractionation schemesCancer198555(9 Suppl)20869510.1002/1097-0142(19850501)55:9+<2086::AID-CNCR2820551409>3.0.CO;2-1Search in Google Scholar
Ho KF, Fowler JF, Sykes AJ, Yap BK, Lee LW, Slevin NJ. IMRT dose fractiona-tion for head and neck cancer: variation in current approaches will make stanardisation different. Acta Oncol 2009; 48: 431–9.HoKFFowlerJFSykesAJYapBKLeeLWSlevinNJIMRT dose fractiona-tion for head and neck cancer: variation in current approaches will make stanardisation differentActa Oncol200948431910.1080/02841860802372272Search in Google Scholar
Lee SW, Back GM, Yi BY, Choi EK, Ahn SD, Shin SS, et al. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006; 65: 152–60.LeeSWBackGMYiBYChoiEKAhnSDShinSSPreliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys2006651526010.1016/j.ijrobp.2005.10.040Search in Google Scholar
Lin SJ, Pan JJ, Han L, Zhang X, Liao X, Lu JJ. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 2009; 75: 1071–8.LinSJPanJJHanLZhangXLiaoXLuJJNasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective seriesInt J Radiat Oncol Biol Phys2009751071810.1016/j.ijrobp.2008.12.015Search in Google Scholar
Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225. J Clin Oncol 2009; 27: 3684–90.LeeNHarrisJGardenASStraubeWGlissonBXiaPIntensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase II trial 0225J Clin Oncol20092736849010.1200/JCO.2008.19.9109Search in Google Scholar
Xiao WW, Huang SM, Han F, Wu SX, Lu LX, Lin CG, et al. Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 2011; 117: 1874–83.XiaoWWHuangSMHanFWuSXLuLXLinCGLocal control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 studyCancer201111718748310.1002/cncr.25754Search in Google Scholar
Bakst RL, Lee N, Pfister DG, Zelefsky MJ, Hunt MA, Kraus DH, et al. Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharygeal carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys 2011; 80: 148–53.BakstRLLeeNPfisterDGZelefskyMJHuntMAKrausDHHypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharygeal carcinoma: a prospective trialInt J Radiat Oncol Biol Phys2011801485310.1016/j.ijrobp.2010.01.026Search in Google Scholar
Wang RS, Wu F, Lu HM, Wei B, Feng G, Li G, et al. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study. J Cancer Res Clin Oncol 2013; 139: 139–45.WangRSWuFLuHMWeiBFengGLiGDefinitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective studyJ Cancer Res Clin Oncol20131391394510.1007/s00432-012-1313-0Search in Google Scholar
Kwong DL, Sham JS, Leung LH, Cheng AC, Ng WM, Kwong PW, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006, 64: 374–81.KwongDLShamJSLeungLHChengACNgWMKwongPWPreliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys2006643748110.1016/j.ijrobp.2005.07.968Search in Google Scholar
Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57–62.WoldenSLChenWCPfisterDGKrausDHBerrySLZelefskyMJIntensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experienceInt J Radiat Oncol Biol Phys200664576210.1016/j.ijrobp.2005.03.057Search in Google Scholar
Bauman G, Yartsev S, Rodrigues G, Lewis C, Venkatesan VM, Yu E, et al. A prospective evaluation of helical tomotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 632–41.BaumanGYartsevSRodriguesGLewisCVenkatesanVMYuEA prospective evaluation of helical tomotherapyInt J Radiat Oncol Biol Phys2007686324110.1016/j.ijrobp.2006.11.052Search in Google Scholar
Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53: 12–22.LeeNXiaPQuiveyJMSultanemKPoonIAkazawaCIntensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experienceInt J Radiat Oncol Biol Phys200253122210.1016/S0360-3016(02)02724-4Search in Google Scholar
Fiorino C, Dell’Oca I, Pierelli A, Broggi S, Cattaneo GM, Chiara A, et al. Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study. Strahlenther Oncol 2007; 183: 497–505.FiorinoCDell’OcaIPierelliABroggiSCattaneoGMChiaraASimultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning studyStrahlenther Oncol200718349750510.1007/s00066-007-1698-xSearch in Google Scholar
Leung SW, Lee TF. Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience. Radiat Oncol 2013; 8: 107–12.LeungSWLeeTFTreatment of nasopharyngeal carcinoma by tomotherapy: five-year experienceRadiat Oncol201381071210.1186/1748-717X-8-107Search in Google Scholar
